Updates matching "Access to Healthcare"

The Centers for Medicare and Medicaid Services (CMS) announced today that they will not approve Massachusetts’ request to restrict Medicaid prescription drug coverage to as few as one drug per class—a practice commonly called a “closed formulary”—unless a state foregoes all manufacturer rebates.

The Department of Labor issued final rules governing the creation of association health plans. Under the rule, AHPs would be exempt from current benefit and cost-sharing requirements.

Patient groups representing millions of Americans with pre-existing conditions filed an amicus curiae or friend of the court brief in the U.S. District Court case, Texas v. United States , citing the devastating impact patients would face should the court side with plaintiffs and move to invalidate the Affordable Care Act.

The Department of Justice (DOJ) announced last night it will not defend several critical patient protections in the health law and instead is arguing to end them. If successful, the case could leave millions of Americans with serious illnesses unable to obtain health care coverage.

Today Virginia governor Ralph Northam signed into law a state budget that extends health care coverage to an estimated 400,000 low-income Virginians through the Medicaid program. Virginia is now the 33 rd state, in addition to Washington, D.C., to accept federal funding to provide health insurance coverage to adults earning less than 138 percent of the federal poverty level—just under $17,000 a year for a single adult. As part of the expansion, Virginia will require Medicaid recipients attend school, work, partake in job training or engage in some kind of community engagement for upwards of 80 hours a month in order to receive benefits. This requirement could pose significant challenges to cancer patients and survivors.

Washington, D.C. – May 22, 2018 – The House of Representatives passed legislation today that, if signed into law, will create a process for accessing experimental drugs without including proper patient protections. The Senate Right-to-Try legislation (S. 204) was strongly opposed by the American Cancer Society Cancer Action Network (ACS

The American Cancer Society Cancer Action Network (ACS CAN), Friends of Cancer Research (FOCR), and the National Organization for Rare Disorders (NORD) along with more than 100 advocacy groups representing millions of patients submitted a letter to Members of the House of Representatives strongly opposing the Senate Right-to-Try Act (S. 204).